Correlation Between Novo Nordisk and Jeudan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Jeudan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Jeudan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Jeudan, you can compare the effects of market volatilities on Novo Nordisk and Jeudan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Jeudan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Jeudan.

Diversification Opportunities for Novo Nordisk and Jeudan

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Novo and Jeudan is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Jeudan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jeudan and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Jeudan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jeudan has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Jeudan go up and down completely randomly.

Pair Corralation between Novo Nordisk and Jeudan

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Jeudan. In addition to that, Novo Nordisk is 1.29 times more volatile than Jeudan. It trades about -0.14 of its total potential returns per unit of risk. Jeudan is currently generating about 0.03 per unit of volatility. If you would invest  20,800  in Jeudan on August 28, 2024 and sell it today you would earn a total of  500.00  from holding Jeudan or generate 2.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  Jeudan

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Jeudan 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Jeudan are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Jeudan is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Novo Nordisk and Jeudan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Jeudan

The main advantage of trading using opposite Novo Nordisk and Jeudan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Jeudan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jeudan will offset losses from the drop in Jeudan's long position.
The idea behind Novo Nordisk AS and Jeudan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities